Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 3, 2010, Pages 1182-1190

  Bidet, Maud ^a,d   Bellanné Chantelot, Christine ^a,d   Galand Portier, Marie Béatrice ^a   Golmard, Jean Louis ^a,d   Tardy, Véronique ^b,e   Morel, Yves ^b,e   Clauin, Séverine ^a   Coussieu, Christiane ^a,d   Boudou, Philippe ^a,f   Mowzowicz, Irene ^a   Bachelot, Anne ^a,d   Touraine, Philippe ^a,d   Kuttenn, Frederique ^a,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Endocrine and Molecular Biochemistry   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITÉ LYON 1   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; STEROID 21 MONOOXYGENASE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; ENZYME DEFICIENCY; FEMALE; FEMALE FERTILITY; GENE MUTATION; HIRSUTISM; HORMONE DETERMINATION; HUMAN; MENSTRUAL CYCLE; MENSTRUATION DISORDER; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; SPONTANEOUS ABORTION; STEROID THERAPY; TREATMENT OUTCOME;

EID: 77749270847     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1383     Document Type: Article

References (40)

1. White PC, Speiser PW 2000 Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245-291
2. Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, Lesser M, New MI, White PC 1992 Disease expression and molecular genotype in adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90:584-595
3. New MI 2006 Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 91:4205-4214
4. Speiser PW 2009 Nonclassic adrenal hyperplasia. Rev Endocr Metab Disorder 10:77-82
5. Mulaikal RM, Migeon CJ, Rock JA 1987 Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 316:178-182
6. Kuhnle U, Bullinger M, Schwarz HP 1995 The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life. Eur J Pediatr 154:708-716
7. Jääskelainen J, Hippeläinen M, Kiekara O, Voutilainen R 2000 Child rate, pregnancy outcome and ovarian function in females with classical 21-hydroxylase deficiency. Acta Obstet Gynecol Scand 79:687-692
8. Krone N, Wachter I, Stefanidou M, Roscher AA, Schwarz HP 2001 Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood. Clin Endocrinol (Oxf) 55:523-529
9. Gastaud F, Bouvattier C, Duranteau L, Brauner R, Thibaud E, Kuttenn F, Bougnères P 2007 Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 92:1391-1396
10. Otten BJ, Stikkelbroeck MM, Claahsen-van der Grinten HL, Hermus AR 2005 Puberty and fertility in congenital adrenal hyperplasia. Endocr Dev 8:54-66
11. Hagenfeldt K, Janson PO, Holmdahl G, Falhammar H, Filipsson H, Frisén L, Thorén M, Nordenskjöld A 2008 Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod 23:1607-1613
12. Casteràs A, De Silva P, Rumsby G, Conway GS 2009 Reassessing fecundity in women with classical congenital adrenal hyperplasia: normal pregnancy rate but reduced fertility rate. Clin Endocrinol (Oxf) 70:833-837
13. Birnbaum MD, Rose LI 1984 Late onset adrenocortical hydroxylase deficiencies associated with menstrual dysfunction. Obstet Gynecol 63:445-451
14. Feldman S, Billaud L, Thalabard JC, Raux-Demay MC, Mowszowicz I, Kuttenn F, Mauvais-Jarvis P 1992 Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 74:635-639
15. Moran C, Azziz R, Weintrob N, Witchel SF, Rohmer V, Dewailly D, Marcondes JA, Pugeat M, Speiser PW, Pignatelli D, Mendonca BB, Bachega TA, Escobar-Morreale HF, Carmina E, Fruzzetti F, Kelestimur F 2006 Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab 91:3451-3456
16. Deneux C, Tardy V, Dib A, Mornet E, Billaud L, Charron D, Morel Y, Kuttenn F 2001 Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 86:207-213
17. Bidet M, Bellanné-Chantelot C, Galand-Portier MB, Tardy V, Billaud L, Laborde K, Coussieu C, Morel Y, Vaury C, Golmard JL, Claustre A, Mornet E, Chakhtoura Z, Mowszowicz I, Bachelot A, Touraine P, Kuttenn F 2009 Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 94:1570-1578
18. Gourmelen M, Pham-Huu-Trung MT, Bredon MG, Girard F 1970 17-Hydroxyprogesterone in the cosyntropin test: results in normal and hirsute women and in mild congenital adrenal hyperplasia. Acta Endocrinol (Copenh) 90:481-489
19. Pham-Huu-Trung MT, Gourmelen M, Raux-Eurin MC, Girard F 1978 Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies. J Clin Endocrinol Metab 47:422-427
20. Fiet J, Gueux B, Gourmelen M, Kuttenn F, Vexiau P, Couillin P, Pham-Huu-Trung MT, Vilette JM, Raux-Demay MC, Galons H 1988 Comparison of basal and andrenocorticotropin-stimulated plasma 21-desoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia. J Clin Endocrinol Metab 66:659-667
21. Kuttenn F, Couillin P, Girard F, Billaud L, Vincens M, Boucekkine C, Thalabard JC, Maudelonde T, Spritzer P, Mowszowicz I, Boue A, Mauvais-Jarvis P 1985 Late-onset adrenal hyperplasia in hirsutism. N Engl J Med 313:224-231
22. Juul S, Karmaus W, Olsen J 1999 Regional differences in waiting time to pregnancy: pregnancy-based surveys from Denmark, France, Germany, Italy and Sweden. The European Infertility and Subfecundity Study Group. Hum Reprod 14:1250-1254
23. Ogilvie CM, Crouch NS, Rumsby G, Creighton SM, Liao LM, Conway GS 2006 Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues. Clin Endocrinol (Oxf) 64:2-11
24. Hoepffner W, Schulze E, Bennek J, Keller E, Willgerodt H 2004 Pregnancies in patients with congenital adrenal hyperplasia with complete or almost complete impairment of 21-hydroxylase activity. Fertil Steril 8:1314-1321
25. Premawardhana LD, Hughes IA, Read GF, Scanlon MF 1997 Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience. Clin Endocrinol (Oxf) 46:327-332
26. Knobil E 1980 The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res 36:53-88
27. Chrousos GP, Loriaux DL, Mann DL, Cutler Jr GB 1982 Late onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease: an allelic variant of congenital virilizing adrenal hyperplasia with a milder enzymatic defect. Ann Intern Med 96:143-148
28. Levin JH, Carmina E, Lobo RA 1991 Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia? Fertil Steril 56:635-640
29. Azziz R, Dewailly D, Owerbach D 1994 Clinical review 56: nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 78:810-815
30. Jia XC, Kessel B, Welsh Jr TH, Hsueh AJ 1985 Androgen inhibition of follicle-stimulating hormone-stimulated luteinizing hormone receptor formation in cultured rat granulosa cells. Endocrinology 117:13-22
31. Thonneau P, Marchand S, Tallec A, Ferial ML, Ducot B, Lansac J, Lopes P, Tabaste JM, Spira A 1991 Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989). Hum Reprod 6:811-816
32. Blayo C 1997 Le point sur l'avortement en France. Populations et Société 325:1-5
33. Ducot B, Spira A 1988 Use of the concept of fecundity in the prognosis of infertility. J Gynecol Obstet Biol Reprod (Paris) 17:461-466
34. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, Armstrong EG, Nisula BC 1988 Incidence of early loss of pregnancy. N Engl J Med 31:189-194
35. Zinaman MJ, Clegg ED, Brown CC, O'Connor J, Selevan SG 1996 Estimates of human fertility and pregnancy loss. Fertil Steril 65:503-509
36. Smith R, Donald RA, Espiner EA, Glatthaar C, Abbott G, Scandrett M 1980 The effect of different treatment regimens on hormonal profiles in congenital adrenal hyperplasia. J Clin Endocrinol Metab 51:230-236
37. Winterer J, Chrousos GP, Loriaux DL, Cutler Jr GB 1985 Effect of hydrocortisone dose schedule on adrenal steroid secretion in congenital adrenal hyperplasia. J Pediatr 106:137-142
38. Spritzer P, Billaud L, Thalabard JC, Birman P, Mowszowicz I, Raux-Demay MC, Clair F, Kuttenn F, Mauvais-Jarvis P 1990 Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. J Clin Endocrinol Metab 70:642-646
39. Practice Committee of the American Society for Reproductive Medicine 2006 Use of clomiphene citrate in women. Fertil Steril 86(Suppl):S187-S193
40. Paperniek E, Zeitlin J, Rivera L, Bucourt M, Topuz B 2003 Preterm birth in a French population: the importance of births by medical decision. BJOG 110:430-432